Cargo Therapeutics (CRGX) Live Share Price, Invest From India

Cargo Therapeutics Stock Performance

as on August 19, 2025 at 6:59 am IST

Day's Low
Day's High
$4.46
Day's Price Range
$4.53
$4.48
0.45%
Downside
1.12%
Upside
52 Week's Low
52 Week's High
$3.78
52-Week Price Range
$4.76
$4.48
15.74%
Downside
6.14%
Upside

Cargo Therapeutics share price movements today

Previous Close: $4.54
Open: $4.53
Volume: 6.2M
Day's Low - High: $4.46 - $4.53
52 Week Low - High: $3.78 - $4.76

Cargo Therapeutics Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cargo Therapeutics Stock Fundamentals & Key Indicators

Check Cargo Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Cargo Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cargo Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cargo Therapeutics	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Analyst Recommendation on Cargo Therapeutics Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cargo Therapeutics. Average target price of $5.5

Cargo Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Cargo Therapeutics.

What analysts predicted

18.55%UPSIDE

Target Price

$5.5

Current Price

$4.48

Analyzed by

10 Analysts

Target

$5.50

Cargo Therapeutics target price $5.5, a slight upside of 18.55% compared to current price of $4.48. According to 10 analysts rating.

Cargo Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	7	-	-
Gross Profit	-	-	-1	-1	-1	-2	-1	-1	-1	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-17	-35	-32	-35	-44	-41	-45	-84	-49
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-580.27%	0.00%	0.00%

Cargo Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-
Gross Profit	0	-1	-3	-7
Operating Income	-	-	-	-
EBITDA	-	-	-	-
Interest Expense	-	-	-	-
Depreciation	-	-	-	-
Income Before Tax	-	-	-	-
Income Tax Expense	-	-	-	-
Net Income	-5	-40	-98	-167
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Insights on Cargo Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.4% return, outperforming this stock by 140.7%
NEGATIVE IMPACT
Price Dip
In the last 1 year, CRGX stock has moved down by -74.3%

About Cargo Therapeutics

CARGO Therapeutics, Inc. is a biotechnology company focused on the development of best-in-class and potentially curative cell therapies for cancer patients. It has a focused pipeline that includes its CRG-023 product candidate, a CD19/CD20/CD22 tri-specific CAR T developed using a tri-cistronic construct and designed to address several known causes of relapse, resulting in a potential best-in-class CAR T-cell therapy across a range of B-cell malignancies with the goal of providing more patients with a durable complete response. Its latest program advancement, an allogeneic platform, is a universal vector solution designed to limit immune-based rejection and enable durable response of CAR T-cell therapy. The universal allogeneic-enabling vector is intended to be paired with any CAR vector to create an allogeneic CAR T-cell therapy, with the potential to maintain the efficacy, durability, and safety of autologous cell therapy while broadening availability to more people with cancer.

Organisation	Cargo Therapeutics
E-voting on shares	Click here to vote

FAQs

What is Cargo Therapeutics share price today?

Cargo Therapeutics share price today is $4.48 as on August 19, 2025 at 1:29 am IST at the close of the market. Cargo Therapeutics share today touched a day high of $4.53 and a low of $4.46.

What is the 52 week high and 52 week low for Cargo Therapeutics share?

Cargo Therapeutics share touched a 52 week high of $4.76 on June 9, 2025 and a 52 week low of $3.78 on May 14, 2025. Cargo Therapeutics stock price today i.e. August 19, 2025 at 1:29 am IST is closed at $4.48,which is 5.78% down from its 52 week high and 18.68% up from its 52 week low.

How to invest in Cargo Therapeutics Stock (CRGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cargo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cargo Therapeutics Shares that will get you 0.3348 shares as per Cargo Therapeutics share price of $4.48 per share as on August 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cargo Therapeutics Stock (CRGX) from India?

Indian investors can start investing in Cargo Therapeutics (CRGX) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 9:25 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Cargo Therapeutics stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 9:25 am IST). Based on Cargo Therapeutics share’s latest price of $4.48 as on August 19, 2025 at 1:29 am IST, you will get 2.2321 shares of Cargo Therapeutics. Learn more about fractional shares .